Editorial: Limitations of randomised controlled trials as evidence of drug safety
Australian Prescriber · 22.08.2023 · 46 (2) · 22-23
DOI: 10.18773/austprescr.2023.005 ↗Kurz gefasst
Editorial in der Zeitschrift Australian Prescriber, online erschienen am 22.08.2023. Verfasst von Tilenka Rj Thynne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, Cardiac and Critical Care, Flinders Medical Centre, Bedford Park, South Australia. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medicine, Cardiac and Critical Care, Flinders Medical Centre, Bedford Park, South Australia.
- College of Medicine and Public Health, Flinders University, Bedford Park, South Australia.
- Acute and Urgent Care, Royal Adelaide Hospital.
- Discipline of Medicine, School of Medicine, Faculty of Health Science, University of Adelaide.
ORCID-Profile: Tilenka Rj Thynne, Genevieve M Gabb
Zitieren
APA
Thynne, T. R., & Gabb, G. M. (2023). Editorial: Limitations of randomised controlled trials as evidence of drug safety. Australian Prescriber, 46(2), 22-23. https://doi.org/10.18773/austprescr.2023.005
Vancouver
Thynne TR, Gabb GM. Editorial: Limitations of randomised controlled trials as evidence of drug safety. Australian Prescriber. 2023;46(2):22-23. doi:10.18773/austprescr.2023.005
BibTeX
@article{Thynne2023,
author = {Thynne, Tilenka Rj and Gabb, Genevieve M},
title = {Editorial: Limitations of randomised controlled trials as evidence of drug safety},
journal = {Australian Prescriber},
year = {2023},
volume = {46},
number = {2},
pages = {22--23},
doi = {10.18773/austprescr.2023.005}
}
EUVIMED